News | March 16, 2012

Microvolt T-Wave Alternans Receive Japanese Reimbursement Coverage

March 16, 2012 - Cambridge Heart Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that its Microvolt T-Wave Alternans (MTWA) test received reimbursement coverage from Japan’s Ministry of Health, Labor and Welfare (MHLW). Effective April 1, 2012, the MTWA Test will be reimbursed for patients who are considered at risk for lethal arrhythmias including, but not limited to, patients with a history of heart attack, cardiomyopathy and Brugada syndrome.

Commenting on the decision, Dr. Takanori Ikeda, Professor of Medicine at Toho University Medical Center, said, “We are very pleased with the reimbursement decision on MTWA testing. A large body of clinical evidence supports the predictive value of the test which can now be used more broadly to help identify and manage the risk of life-threatening arrhythmias.”

Cambridge Heart markets its MTWA technology in Japan through its partnership with Fukuda Denshi Corporation, one of Japan’s leading and most active medical device and technology companies, which has already established an MTWA user base in the country, noted Ali Haghighi-Mood, Cambridge Heart president and CEO.

“This decision highlights the valuable role that MTWA can play in managing a patient’s risk for sudden cardiac arrest,” Haghighi-Mood said. “Gaining reimbursement coverage in Japan, which enjoys one of the most advanced healthcare systems in the world, is an important milestone for our MTWA technology and another indicator that the value of MTWA testing is being recognized around the world. We look forward to working closely and strategically with our distribution partner in Japan to further expand that market and maximize the value of the relationship.”

For more information:

Related Content

HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG | January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
AirStrip One, ECG management, web client, U.S. clearance
Technology | ECG | October 11, 2016
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One...
Carestream, Vue Motion universal viewer, ECG waveforms, diagnostic reading, FDA clearance

Image courtesy of Carestream Health

Technology | ECG | November 20, 2015
Carestream has obtained U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of electrocardiogram (...
CardioSecur mobile ECG, 22-lead, 360 degree view of the heart, CardioSecur Pro

Image courtesy of CardioSecur

Technology | ECG | October 08, 2015
Personal MedSystems introduced the first and only 22-lead mobile electrocardiogram (ECG) system, CardioSecur, at the...
Mortara, ELI 280, TouchScreen ECG, ECG advances, new ECG technology

The Mortara Eli 280 is part of a new generation of ECG systems that integrate touchscreen monitors to improve workflow.

Feature | ECG | September 16, 2015 | Dave Fornell
The resting electrocardiogram (ECG) has been us
Overlay Init